Advertisement
Screener

Myomo, Inc. (MYO) Graph

MYO Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $11.70M; Cost of revenue (m); Research and development $1.72M; Selling, general and administrative (m).
  • 2026-03-31: Revenue $10.11M; Cost of revenue (m); Research and development $1.62M; Selling, general and administrative (m).
  • 2025-12-31: Revenue $11.35M*; Cost of revenue (m); Research and development $1.62M*; Selling, general and administrative (m).
  • 2025-09-30: Revenue $10.09M; Cost of revenue (m); Research and development $1.53M; Selling, general and administrative (m).

Major Customers

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MYO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Clinical AndMedical Providers$3.53MDirect To Patient$8.18MRevenue$11.70MGross profit$8.44MOperating expenses$10.70MOperating income-$2.25MOther income, net-$1.74MResearch & development$1.72MPre-tax income-$3.99MIncome tax$31.40KNet income-$4.02M

Concentration Risk By Benchmark

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MYO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Sales Revenue Segment$11.70MRevenue$11.70MGross profit$8.44MOperating expenses$10.70MOperating income-$2.25MOther income, net-$1.74MResearch & development$1.72MPre-tax income-$3.99MIncome tax$31.40KNet income-$4.02M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$11.70M(m)$1.72M(m)$10.70M$31.40K-$4.02M
2026-03-31$10.11M(m)$1.62M(m)$10.06M$186.72K-$3.01M
2025-12-31$11.35M*(m)$1.62M*(m)$10.56M*$83.88K*(m)
2025-09-30$10.09M(m)$1.53M(m)$9.96M$135.66K-$3.66M
2025-06-30$9.65M(m)$2.00M(m)$10.64M$148.20K-$4.63M
2025-03-31$9.83M(m)$1.79M(m)$10.13M$136.79K-$3.47M
2024-09-30$9.21M(m)$1.25M(m)$7.90M$84.88K-$966.41K
2024-06-30$7.52M(m)$1.01M(m)$6.44M$113.78K-$1.12M
2024-03-31$3.75M(m)$956.22K(m)$6.19M$82.16K-$3.84M
2023-12-31(m)(m)(m)$4.66M*(m)(m)(m)
2023-09-30$5.08M(m)$717.26K$4.80M$5.51M$46.36K-$2.03M
2023-06-30$5.96M(m)$564.24K$4.82M$5.38M-$3.56K-$1.01M
2023-03-31$3.45M$1.14M$476.99K$4.50M$4.98M$42.41K-$2.64M
2022-09-30$3.97M$1.33M$690.41K$4.77M$5.46M$23.38K-$2.83M
2022-06-30$3.68M$1.28M$632.87K$4.66M$5.30M-$6.43K-$2.91M
2022-03-31$3.87M$1.29M$659.54K$4.66M$5.32M$76.25K-$2.81M
2021-09-30$4.38M$1.11M$641.23K$4.66M$5.30M$22.70K-$2.06M
2021-06-30$3.10M$901.57K$600.12K$4.20M$4.80M$15.66K-$2.62M
2021-03-31$2.34M(m)$525.97K$4.12M$4.65M$28.24K-$2.96M
2020-09-30$1.93M(m)$345.67K$3.27M$3.62M$1.15K-$2.78M
2020-06-30$858.59K(m)$397.81K$2.89M$3.29M$1.08K-$3.29M
2020-03-31$1.01M(m)$506.95K$3.60M$4.11M$613.00-$3.80M
2019-09-30$606.62K(m)$433.06K$2.67M$3.10M(m)-$2.79M
2019-06-30$880.35K(m)$427.57K$2.78M$3.21M(m)-$2.57M
2019-03-31$830.07K(m)$446.35K$2.78M$3.23M(m)-$2.60M
2018-09-30$608.98K$193.58K$449.67K$2.67M$3.12M(m)-$2.65M
2018-06-30$632.37K$200.45K$486.98K$2.63M$3.11M(m)-$2.63M
2018-03-31$313.18K(m)$372.36K$2.24M$2.61M(m)-$2.35M
2017-09-30$488.54K$124.10K$329.36K$1.47M$1.80M(m)-$1.26M
2017-06-30$306.68K$98.64K$708.62K$1.43M$2.14M(m)-$7.38M
2017-03-31$216.23K$78.57K$356.88K$1.14M$1.50M(m)-$1.56M
2016-09-30$184.19K$77.08K$237.69K$803.25K$1.04M(m)-$1.02M
2016-06-30$254.07K$50.19K$258.28K$634.18K$892.46K(m)-$759.89K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$21.82M(m)$3.34M(m)$20.76M$218.12K-$7.03M
2025-06-30$19.48M(m)$3.79M(m)$20.77M$285.00K-$8.10M
2024-06-30$11.28M(m)$1.96M(m)$12.63M$195.94K-$4.96M
2023-06-30$9.41M(m)$1.04M$9.32M$10.36M$38.85K-$3.66M
2022-06-30$7.55M$2.57M$1.29M$9.32M$10.61M$69.82K-$5.72M
2021-06-30$5.44M(m)$1.13M$8.32M$9.45M$43.91K-$5.58M
2020-06-30$1.87M(m)$904.76K$6.50M$7.40M$1.70K-$7.09M
2019-06-30$1.71M(m)$873.92K$5.56M$6.43M(m)-$5.16M
2018-06-30$945.55K(m)$859.34K$4.86M$5.72M(m)-$4.97M
2017-06-30$522.91K$177.21K$1.07M$2.58M$3.64M(m)-$8.94M
2016-06-30$470.99K$109.25K$471.37K$1.14M$1.61M(m)-$1.39M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$29.57M(m)$5.32M(m)$30.73M$420.65K-$11.76M
2024-09-30$20.48M(m)$3.21M(m)$20.53M$280.82K-$5.92M
2023-09-30$14.48M(m)$1.76M$14.12M$15.88M$85.20K-$5.69M
2022-09-30$11.51M$3.89M$1.98M$14.09M$16.07M$93.20K-$8.55M
2021-09-30$9.82M(m)$1.77M$12.98M$14.75M$66.60K-$7.64M
2020-09-30$3.79M(m)$1.25M$9.77M$11.02M$2.85K-$9.87M
2019-09-30$2.32M(m)$1.31M$8.23M$9.54M(m)-$7.95M
2018-09-30$1.55M(m)$1.31M$7.54M$8.85M(m)-$7.62M
2017-09-30$1.01M(m)$1.39M$4.05M$5.44M(m)-$10.20M
2016-09-30$655.18K$186.33K$714.33K$1.93M$2.65M(m)-$2.41M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$40.93M(m)$6.94M(m)$41.29M$504.53K-$15.60M
2024-12-31$32.55M(m)$4.77M(m)$29.39M$365.62K-$6.20M
2023-12-31$19.24M(m)$2.64M$18.78M$21.41M$156.00K-$8.10M
2022-12-31$15.56M$5.30M$2.48M$18.44M$20.93M$69.94K-$10.72M
2021-12-31$13.86M(m)$2.56M$18.02M$20.58M$88.93K-$10.37M
2020-12-31$7.58M(m)$1.67M$13.82M$15.49M(m)-$11.56M
2019-12-31$3.84M(m)$1.75M$11.46M$13.21M(m)-$10.71M
2018-12-31$2.44M(m)$1.84M$10.41M$12.24M(m)-$10.32M
2017-12-31$1.56M(m)$1.75M$5.85M$7.60M$0.00-$12.10M
2016-12-31$1.10M$282.16K$1.12M$2.98M$4.10M$0.00-$3.62M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
Safe Pro Group Inc. (SPAI)United States$0.090B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Lifeward Ltd. (LFWD)$0.021B
Conexeu Sciences Inc. (CNXU)United States$0.111B
ENvue Medical, Inc. (FEED)United States$0.011B
Bone Biologics Corp (BBLG)United States$0.001B